Shree Ram Singh

Employment

• National Cancer Institute Scientific Review Officer
  2020 - Present
• National Cancer Institute Mouse Cancer Genetics Program Staff Scientist
  2011 - 2020
• National Cancer Institute Research Fellow
  2008 - 2011
• National Cancer Instutute Postdoctoral Fellow
  2003 - 2008
• University of Haifa Postdoctoral Fellow
  2002 - 2003
• Goethe University Frankfurt Scientist
  2001 - 2001
• Goethe University Frankfurt Scientist
  1998 - 1998

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (173)

• Disruption of the lipolysis pathway results in stem cell death through a sterile immunity-like pathway in adult Drosophila.
  Cell reports 2022 DOI: 10.1016/j.celrep.2022.110958
  +Save
• Combination Methionine-methylation-axis Blockade: A Novel Approach to Target the Methionine Addiction of Cancer.
  Cancer genomics & proteomics 2021 DOI: 10.21873/cgp.20246
  +Save
• Mouse Genetics
  Methods in Molecular Biology 2021 DOI: 10.1007/978-1-0716-1008-4
  +Save
• A novel patient-derived orthotopic xenograft (PDOX) mouse model of highly-aggressive liver metastasis for identification of candidate effective drug-combinations.
  Scientific reports 2020 DOI: 10.1038/s41598-020-76708-9
  +Save
• Ischemia reperfusion-induced metastasis is resistant to PPARγ agonist pioglitazone in a murine model of colon cancer.
  Scientific reports 2020 DOI: 10.1038/s41598-020-75210-6
  +Save
• Oral recombinant methioninase increases TRAIL receptor-2 expression to regress pancreatic cancer in combination with agonist tigatuzumab in an orthotopic mouse model.
  Cancer letters 2020 DOI: 10.1016/j.canlet.2020.07.034
  +Save
• Osimertinib regressed an EGFR-mutant lung-adenocarcinoma bone-metastasis mouse model and increased long-term survival.
  Translational oncology 2020 DOI: 10.1016/j.tranon.2020.100826
  +Save
• Eribulin Regresses a Doxorubicin-resistant Dedifferentiated Liposarcoma in a Patient-derived Orthotopic Xenograft Mouse Model.
  Cancer genomics & proteomics 2020 DOI: 10.21873/cgp.20194
  +Save
• A Novel Anionic-phosphate-platinum Complex Effectively Targets a Cisplatinum-resistant Osteosarcoma in a Patient-derived Orthotopic Xenograft Mouse Model.
  Cancer genomics & proteomics 2020 DOI: 10.21873/cgp.20182
  +Save
• A Single Low Dose of Eribulin Regressed a Highly Aggressive Triple-negative Breast Cancer in a Patient-derived Orthotopic Xenograft Model.
  Anticancer research 2020 DOI: 10.21873/anticanres.14218
  +Save